[1]
Lingyan He et al. 2024. Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus. Archives of Rheumatology. 39, 2 (Jun. 2024), 172–179. DOI:https://doi.org/10.46497/ArchRheumatol.2024.9977.